Predictors of Early Diabetic Retinopathy Regression with Ranibizumab in the RIDE and RISE Clinical Trials

PURPOSE: To investigate the predictors of early diabetic retinopathy (DR) improvement in the RIDE/RISE (NCT00473382/NCT00473330) clinical trials. PATIENTS AND METHODS: In RIDE/RISE, adult patients with vision loss due to diabetic macular edema (DME) were randomized to monthly intravitreal ranibizuma...

Descripción completa

Detalles Bibliográficos
Autores principales: Singer, Michael, Liu, Mimi, Schlottmann, Patricio G, Khanani, Arshad M, Hemphill, Miranda, Hill, Lauren, Tuomi, Lisa, Haskova, Zdenka
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306476/
https://www.ncbi.nlm.nih.gov/pubmed/32606578
http://dx.doi.org/10.2147/OPTH.S247061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7306476/
https://www.ncbi.nlm.nih.gov/pubmed/32606578
http://dx.doi.org/10.2147/OPTH.S247061

Ejemplares similares